|
|
|
Volumn 2, Issue I, 2000, Pages
|
|
Benefits of ACE inhibitors: What remains to be proven?
a
|
|
Author keywords
ACE inhibitors; Coronary events; Diabetes; Heart failure; Hypertension
|
|
Indexed keywords
AMLODIPINE;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISOPROLOL;
CANDESARTAN;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
FOSINOPRIL;
LISINOPRIL;
LOSARTAN;
METOPROLOL;
NIFEDIPINE;
NISOLDIPINE;
PERINDOPRIL;
RAMIPRIL;
TRANDOLAPRIL;
CARDIOVASCULAR RISK;
CLINICAL PRACTICE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIABETES MELLITUS;
HEART FAILURE;
HUMAN;
META ANALYSIS;
PRIORITY JOURNAL;
|
|
EID: 0033906472
PISSN: 1520765X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (37)
|
